VanEck Associates’s Silver Standard Resources SSRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-13,126,237
| Closed | -$127M | – | 759 |
|
|
2017
Q2 | $127M | Sell |
13,126,237
-9,123,286
| -41% | -$91.6M | 0.7% | 37 |
|
|
2017
Q1 | $236M | Buy |
22,249,523
+536,968
| +2% | +$5.68M | 1.04% | 17 |
|
|
2016
Q4 | $194M | Sell |
21,712,555
-390,524
| -2% | -$3.95M | 0.97% | 19 |
|
|
2016
Q3 | $267M | Buy |
22,103,079
+4,122,193
| +23% | +$55.6M | 1.24% | 16 |
|
|
2016
Q2 | $234M | Buy |
17,980,886
+11,498,367
| +177% | +$107M | 1.2% | 19 |
|
|
2016
Q1 | $36M | Buy |
6,482,519
+710,770
| +12% | +$3.75M | 0.24% | 86 |
|
|
2015
Q4 | $29.9M | Buy |
5,771,749
+239,744
| +4% | +$1.44M | 0.24% | 104 |
|
|
2015
Q3 | $36.1M | Sell |
5,532,005
-70,013
| -1% | -$426K | 0.28% | 90 |
|
|
2015
Q2 | $35.2M | Sell |
5,602,018
-1,273,159
| -19% | -$7.52M | 0.21% | 117 |
|
|
2015
Q1 | $31.1M | Buy |
6,875,177
+1,540,438
| +29% | +$8.56M | 0.18% | 120 |
|
|
2014
Q4 | $26.7M | Sell |
5,334,739
-6,674,526
| -56% | -$35.1M | 0.17% | 126 |
|
|
2014
Q3 | $73.3M | Sell |
12,009,265
-987,367
| -8% | -$8.43M | 0.39% | 62 |
|
|
2014
Q2 | $113M | Buy |
12,996,632
+782,232
| +6% | +$6.76M | 0.52% | 50 |
|
|
2014
Q1 | $121M | Buy |
12,214,400
+6,677,559
| +121% | +$62.7M | 0.6% | 45 |
|
|
2013
Q4 | $38.5M | Buy |
5,536,841
+5,529,412
| +74,430% | +$33.4M | 0.19% | 96 |
|
|
2013
Q3 | $46K | Sell |
7,429
-5,957,582
| -100% | -$44.6M | ﹤0.01% | 634 |
|
|
2013
Q2 | $37.8M | Buy |
+5,965,011
| New | +$44M | 0.21% | 85 |
|
Other funds holding SSRI
VanEck Associates's SSRI Position: Q3 2017 in Review
VanEck Associates sold out of Silver Standard Resources (SSRI) in Q3 2017, closing a stake of 13,126,237 shares — an estimated $127M sold.
VanEck Associates first reported a position in SSRI in Q2 2013 and held it in 17 quarters. The position peaked at $267M in Q3 2016. 1 fund tracked by Wall St. Rank holds SSRI as of Q3 2017.
- VanEck Associates reported no remaining Silver Standard Resources position as of Q3 2017 after selling out during the quarter.
- VanEck Associates sold 13,126,237 Silver Standard Resources shares in Q3 2017, an estimated $127M.
- VanEck Associates first reported a position in Silver Standard Resources in Q2 2013 and held it in 17 quarters.
- VanEck Associates's Silver Standard Resources position peaked at $267M in Q3 2016.
- 1 fund tracked by Wall St. Rank held Silver Standard Resources as of Q3 2017.
Based on VanEck Associates's 13F filing for Q3 2017, filed 9 Nov 2017.